|
|
|
Insider
Information: |
Levin Arthur A |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
16,504 |
|
Indirect Shares
|
271,851 |
|
|
Direct
Value |
$469,490 |
|
|
Indirect Value
|
$6,968,786 |
|
|
Total
Shares |
288,355 |
|
|
Total
Value |
$7,438,277 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
3
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
3.0
|
Percentage
Gain/Loss : |
0.0%
|
39.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ionis Pharmaceuticals Inc |
IONS |
Vice President |
2007-04-25 |
1,674 |
2003-07-01 |
0 |
Premium* |
|
Stoke Therapeutics, Inc. |
STOK |
Director |
2021-03-01 |
0 |
2021-03-01 |
17,979 |
Premium* |
|
Avidity Biosciences, Inc. |
RNA |
Director |
2024-05-20 |
14,830 |
2024-05-20 |
253,872 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
71 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RNA |
Avidity Biosciences, Inc. |
Chief Scientific Officer |
|
2022-12-29 |
4 |
AS |
$22.01 |
$880,568 |
D/D |
(40,000) |
1,330 |
0 |
% |
|
RNA |
Avidity Biosciences, Inc. |
Chief Scientific Officer |
|
2023-01-12 |
4 |
AS |
$22.00 |
$220,028 |
D/D |
(10,000) |
1,330 |
0 |
% |
|
RNA |
Avidity Biosciences, Inc. |
Chief Scientific Officer |
|
2023-01-12 |
4 |
OE |
$1.24 |
$12,400 |
D/D |
10,000 |
11,330 |
0 |
- |
|
RNA |
Avidity Biosciences, Inc. |
Chief Scientific Officer |
|
2023-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
18,000 |
19,330 |
0 |
- |
|
RNA |
Avidity Biosciences, Inc. |
Chief Scientific Officer |
|
2023-02-14 |
4 |
AS |
$23.62 |
$236,567 |
D/D |
(10,000) |
19,330 |
0 |
% |
|
RNA |
Avidity Biosciences, Inc. |
Chief Scientific Officer |
|
2023-02-14 |
4 |
OE |
$1.24 |
$12,400 |
D/D |
10,000 |
29,330 |
0 |
- |
|
RNA |
Avidity Biosciences, Inc. |
Director |
|
2023-03-15 |
4 |
AS |
$22.01 |
$2,201 |
D/D |
(100) |
19,330 |
0 |
% |
|
RNA |
Avidity Biosciences, Inc. |
Director |
|
2023-03-15 |
4 |
OE |
$1.24 |
$124 |
D/D |
100 |
19,430 |
0 |
- |
|
RNA |
Avidity Biosciences, Inc. |
Director |
|
2024-01-22 |
4 |
AS |
$10.13 |
$18,832 |
D/D |
(1,859) |
17,471 |
0 |
% |
|
RNA |
Avidity Biosciences, Inc. |
Director |
|
2024-03-12 |
4 |
S |
$22.00 |
$609,017 |
D/D |
(27,641) |
14,830 |
0 |
% |
|
RNA |
Avidity Biosciences, Inc. |
Director |
|
2024-03-12 |
4 |
OE |
$1.24 |
$31,000 |
D/D |
25,000 |
42,471 |
0 |
- |
|
RNA |
Avidity Biosciences, Inc. |
Director |
|
2024-03-19 |
4 |
S |
$23.97 |
$119,848 |
D/D |
(5,000) |
14,830 |
0 |
% |
|
RNA |
Avidity Biosciences, Inc. |
Director |
|
2024-03-19 |
4 |
OE |
$1.24 |
$6,200 |
D/D |
5,000 |
19,830 |
0 |
- |
|
RNA |
Avidity Biosciences, Inc. |
Director |
|
2024-04-03 |
4 |
S |
$27.11 |
$542,214 |
I/I |
(20,000) |
253,872 |
0 |
% |
|
RNA |
Avidity Biosciences, Inc. |
Director |
|
2024-04-19 |
4 |
AS |
$22.82 |
$114,123 |
D/D |
(5,000) |
14,830 |
0 |
% |
|
RNA |
Avidity Biosciences, Inc. |
Director |
|
2024-04-19 |
4 |
OE |
$1.24 |
$6,200 |
D/D |
5,000 |
19,830 |
0 |
- |
|
RNA |
Avidity Biosciences, Inc. |
Director |
|
2024-05-20 |
4 |
AS |
$29.90 |
$149,481 |
D/D |
(5,000) |
14,830 |
0 |
% |
|
RNA |
Avidity Biosciences, Inc. |
Director |
|
2024-05-20 |
4 |
OE |
$1.24 |
$6,200 |
D/D |
5,000 |
19,830 |
0 |
- |
|
STOK |
Stoke Therapeutics, Inc. |
Director |
|
2019-06-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
17,979 |
|
- |
|
STOK |
Stoke Therapeutics, Inc. |
Director |
|
2021-03-01 |
4 |
AS |
$60.55 |
$759,841 |
D/D |
(12,500) |
0 |
0 |
- |
|
STOK |
Stoke Therapeutics, Inc. |
Director |
|
2021-03-01 |
4 |
OE |
$0.40 |
$6,576 |
D/D |
12,500 |
12,500 |
0 |
- |
|
71 Records found
|
|
Page 3 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|